Dr. Loïc Renaud is an oncologist and hematologist in the Department of Hematology at Gustave Roussy, France, specialising in chronic lymphoproliferative disorders including Hodgkin and non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL). He is also a Post-Doctoral Fellow in the Landau Lab at Weill Cornell Medical College, New York, with research focused on lymphoma and CLL from first-line therapy to Phase I trials, including therapeutic intensification and CAR-T cell therapies. An active member of LYSA since 2021, he has contributed to clinical recommendations for Hodgkin lymphoma and DLBCL and serves as co-coordinator of PMBL recommendations. He is principal investigator and co-investigator of multiple Phase II and III trials in lymphoid hematological diseases.